Empire Company Limited
Empire Company Limited (EMLAF) Stock Competitors & Peer Comparison
See (EMLAF) competitors and their performances in Stock Market.
Peer Comparison Table: Grocery Stores Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| EMLAF | $33.66 | -0.38% | 7.7B | 68.69 | $0.49 | +1.89% |
| LBLCF | $44.23 | +0.51% | 51.8B | 27.66 | $1.61 | +0.92% |
| TSCDY | $17.96 | -4.44% | 38.7B | 16.63 | $1.10 | +3.14% |
| TSCDF | $6.14 | -3.91% | 38.1B | 16.24 | $0.37 | +3.25% |
| ADRNY | $42.84 | +0.13% | 37.6B | 14.36 | $2.97 | +3.41% |
| AHODF | $42.65 | +4.66% | 36.3B | 13.87 | $2.97 | +3.51% |
| WOLWF | $26.50 | +0.00% | 32.4B | 48.18 | $0.55 | +2.30% |
| SVNDY | $11.71 | -1.10% | 27B | 15.37 | $0.76 | +2.69% |
| WNGRF | $69.74 | -0.90% | 26.2B | 35.26 | $1.97 | +1.25% |
| SVNDF | $11.80 | +4.70% | 26.1B | 14.83 | $0.76 | +2.93% |
Stock Comparison
EMLAF vs LBLCF Comparison May 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 7.7B. In comparison, LBLCF has a market cap of 51.8B. Regarding current trading prices, EMLAF is priced at $33.66, while LBLCF trades at $44.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 68.69, whereas LBLCF's P/E ratio is 27.66. In terms of profitability, EMLAF's ROE is +0.02%, compared to LBLCF's ROE of +0.25%. Regarding short-term risk, EMLAF is less volatile compared to LBLCF. This indicates potentially lower risk in terms of short-term price fluctuations for EMLAF.Check LBLCF's competition here
EMLAF vs TSCDY Comparison May 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 7.7B. In comparison, TSCDY has a market cap of 38.7B. Regarding current trading prices, EMLAF is priced at $33.66, while TSCDY trades at $17.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 68.69, whereas TSCDY's P/E ratio is 16.63. In terms of profitability, EMLAF's ROE is +0.02%, compared to TSCDY's ROE of +0.16%. Regarding short-term risk, EMLAF is less volatile compared to TSCDY. This indicates potentially lower risk in terms of short-term price fluctuations for EMLAF.Check TSCDY's competition here
EMLAF vs TSCDF Comparison May 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 7.7B. In comparison, TSCDF has a market cap of 38.1B. Regarding current trading prices, EMLAF is priced at $33.66, while TSCDF trades at $6.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 68.69, whereas TSCDF's P/E ratio is 16.24. In terms of profitability, EMLAF's ROE is +0.02%, compared to TSCDF's ROE of +0.16%. Regarding short-term risk, EMLAF is more volatile compared to TSCDF. This indicates potentially higher risk in terms of short-term price fluctuations for EMLAF.Check TSCDF's competition here
EMLAF vs ADRNY Comparison May 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 7.7B. In comparison, ADRNY has a market cap of 37.6B. Regarding current trading prices, EMLAF is priced at $33.66, while ADRNY trades at $42.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 68.69, whereas ADRNY's P/E ratio is 14.36. In terms of profitability, EMLAF's ROE is +0.02%, compared to ADRNY's ROE of +0.16%. Regarding short-term risk, EMLAF is less volatile compared to ADRNY. This indicates potentially lower risk in terms of short-term price fluctuations for EMLAF.Check ADRNY's competition here
EMLAF vs AHODF Comparison May 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 7.7B. In comparison, AHODF has a market cap of 36.3B. Regarding current trading prices, EMLAF is priced at $33.66, while AHODF trades at $42.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 68.69, whereas AHODF's P/E ratio is 13.87. In terms of profitability, EMLAF's ROE is +0.02%, compared to AHODF's ROE of +0.16%. Regarding short-term risk, EMLAF is more volatile compared to AHODF. This indicates potentially higher risk in terms of short-term price fluctuations for EMLAF.Check AHODF's competition here
EMLAF vs WOLWF Comparison May 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 7.7B. In comparison, WOLWF has a market cap of 32.4B. Regarding current trading prices, EMLAF is priced at $33.66, while WOLWF trades at $26.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 68.69, whereas WOLWF's P/E ratio is 48.18. In terms of profitability, EMLAF's ROE is +0.02%, compared to WOLWF's ROE of +0.13%. Regarding short-term risk, EMLAF is more volatile compared to WOLWF. This indicates potentially higher risk in terms of short-term price fluctuations for EMLAF.Check WOLWF's competition here
EMLAF vs SVNDY Comparison May 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 7.7B. In comparison, SVNDY has a market cap of 27B. Regarding current trading prices, EMLAF is priced at $33.66, while SVNDY trades at $11.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 68.69, whereas SVNDY's P/E ratio is 15.37. In terms of profitability, EMLAF's ROE is +0.02%, compared to SVNDY's ROE of +0.08%. Regarding short-term risk, EMLAF is less volatile compared to SVNDY. This indicates potentially lower risk in terms of short-term price fluctuations for EMLAF.Check SVNDY's competition here
EMLAF vs WNGRF Comparison May 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 7.7B. In comparison, WNGRF has a market cap of 26.2B. Regarding current trading prices, EMLAF is priced at $33.66, while WNGRF trades at $69.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 68.69, whereas WNGRF's P/E ratio is 35.26. In terms of profitability, EMLAF's ROE is +0.02%, compared to WNGRF's ROE of +0.22%. Regarding short-term risk, EMLAF is more volatile compared to WNGRF. This indicates potentially higher risk in terms of short-term price fluctuations for EMLAF.Check WNGRF's competition here
EMLAF vs SVNDF Comparison May 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 7.7B. In comparison, SVNDF has a market cap of 26.1B. Regarding current trading prices, EMLAF is priced at $33.66, while SVNDF trades at $11.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 68.69, whereas SVNDF's P/E ratio is 14.83. In terms of profitability, EMLAF's ROE is +0.02%, compared to SVNDF's ROE of +0.08%. Regarding short-term risk, EMLAF is less volatile compared to SVNDF. This indicates potentially lower risk in terms of short-term price fluctuations for EMLAF.Check SVNDF's competition here
EMLAF vs CLEGF Comparison May 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 7.7B. In comparison, CLEGF has a market cap of 21.5B. Regarding current trading prices, EMLAF is priced at $33.66, while CLEGF trades at $16.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 68.69, whereas CLEGF's P/E ratio is 29.09. In terms of profitability, EMLAF's ROE is +0.02%, compared to CLEGF's ROE of +0.26%. Regarding short-term risk, EMLAF is less volatile compared to CLEGF. This indicates potentially lower risk in terms of short-term price fluctuations for EMLAF.Check CLEGF's competition here
EMLAF vs KKOYY Comparison May 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 7.7B. In comparison, KKOYY has a market cap of 18.8B. Regarding current trading prices, EMLAF is priced at $33.66, while KKOYY trades at $11.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 68.69, whereas KKOYY's P/E ratio is 19.38. In terms of profitability, EMLAF's ROE is +0.02%, compared to KKOYY's ROE of +0.15%. Regarding short-term risk, EMLAF is less volatile compared to KKOYY. This indicates potentially lower risk in terms of short-term price fluctuations for EMLAF.Check KKOYY's competition here
EMLAF vs CRRFY Comparison May 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 7.7B. In comparison, CRRFY has a market cap of 14.4B. Regarding current trading prices, EMLAF is priced at $33.66, while CRRFY trades at $4.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 68.69, whereas CRRFY's P/E ratio is 12.33. In terms of profitability, EMLAF's ROE is +0.02%, compared to CRRFY's ROE of +0.03%. Regarding short-term risk, EMLAF is less volatile compared to CRRFY. This indicates potentially lower risk in terms of short-term price fluctuations for EMLAF.Check CRRFY's competition here
EMLAF vs CRERF Comparison May 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 7.7B. In comparison, CRERF has a market cap of 14.2B. Regarding current trading prices, EMLAF is priced at $33.66, while CRERF trades at $20.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 68.69, whereas CRERF's P/E ratio is 12.04. In terms of profitability, EMLAF's ROE is +0.02%, compared to CRERF's ROE of +0.03%. Regarding short-term risk, EMLAF is more volatile compared to CRERF. This indicates potentially higher risk in terms of short-term price fluctuations for EMLAF.Check CRERF's competition here
EMLAF vs MTRAF Comparison May 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 7.7B. In comparison, MTRAF has a market cap of 13.6B. Regarding current trading prices, EMLAF is priced at $33.66, while MTRAF trades at $64.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 68.69, whereas MTRAF's P/E ratio is 18.73. In terms of profitability, EMLAF's ROE is +0.02%, compared to MTRAF's ROE of +0.14%. Regarding short-term risk, EMLAF is more volatile compared to MTRAF. This indicates potentially higher risk in terms of short-term price fluctuations for EMLAF.Check MTRAF's competition here
EMLAF vs CVPBF Comparison May 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 7.7B. In comparison, CVPBF has a market cap of 13.1B. Regarding current trading prices, EMLAF is priced at $33.66, while CVPBF trades at $1.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 68.69, whereas CVPBF's P/E ratio is 14.70. In terms of profitability, EMLAF's ROE is +0.02%, compared to CVPBF's ROE of +0.22%. Regarding short-term risk, EMLAF is less volatile compared to CVPBF. This indicates potentially lower risk in terms of short-term price fluctuations for EMLAF.Check CVPBF's competition here
EMLAF vs CVPUF Comparison May 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 7.7B. In comparison, CVPUF has a market cap of 11.6B. Regarding current trading prices, EMLAF is priced at $33.66, while CVPUF trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 68.69, whereas CVPUF's P/E ratio is 13.00. In terms of profitability, EMLAF's ROE is +0.02%, compared to CVPUF's ROE of +0.22%. Regarding short-term risk, EMLAF is more volatile compared to CVPUF. This indicates potentially higher risk in terms of short-term price fluctuations for EMLAF.Check CVPUF's competition here
EMLAF vs CPPCY Comparison May 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 7.7B. In comparison, CPPCY has a market cap of 11.5B. Regarding current trading prices, EMLAF is priced at $33.66, while CPPCY trades at $12.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 68.69, whereas CPPCY's P/E ratio is 13.34. In terms of profitability, EMLAF's ROE is +0.02%, compared to CPPCY's ROE of +0.21%. Regarding short-term risk, EMLAF is less volatile compared to CPPCY. This indicates potentially lower risk in terms of short-term price fluctuations for EMLAF.Check CPPCY's competition here
EMLAF vs JSNSF Comparison May 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 7.7B. In comparison, JSNSF has a market cap of 10.4B. Regarding current trading prices, EMLAF is priced at $33.66, while JSNSF trades at $4.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 68.69, whereas JSNSF's P/E ratio is 19.38. In terms of profitability, EMLAF's ROE is +0.02%, compared to JSNSF's ROE of +0.06%. Regarding short-term risk, EMLAF is more volatile compared to JSNSF. This indicates potentially higher risk in terms of short-term price fluctuations for EMLAF.Check JSNSF's competition here
EMLAF vs KKOYF Comparison May 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 7.7B. In comparison, KKOYF has a market cap of 9.6B. Regarding current trading prices, EMLAF is priced at $33.66, while KKOYF trades at $23.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 68.69, whereas KKOYF's P/E ratio is 22.20. In terms of profitability, EMLAF's ROE is +0.02%, compared to KKOYF's ROE of +0.15%. Regarding short-term risk, EMLAF is more volatile compared to KKOYF. This indicates potentially higher risk in terms of short-term price fluctuations for EMLAF.Check KKOYF's competition here
EMLAF vs JSAIY Comparison May 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 7.7B. In comparison, JSAIY has a market cap of 9.2B. Regarding current trading prices, EMLAF is priced at $33.66, while JSAIY trades at $16.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 68.69, whereas JSAIY's P/E ratio is 17.07. In terms of profitability, EMLAF's ROE is +0.02%, compared to JSAIY's ROE of +0.06%. Regarding short-term risk, EMLAF is less volatile compared to JSAIY. This indicates potentially lower risk in terms of short-term price fluctuations for EMLAF.Check JSAIY's competition here
EMLAF vs DNOPY Comparison May 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 7.7B. In comparison, DNOPY has a market cap of 8B. Regarding current trading prices, EMLAF is priced at $33.66, while DNOPY trades at $8.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 68.69, whereas DNOPY's P/E ratio is 18.50. In terms of profitability, EMLAF's ROE is +0.02%, compared to DNOPY's ROE of +0.19%. Regarding short-term risk, EMLAF is less volatile compared to DNOPY. This indicates potentially lower risk in terms of short-term price fluctuations for EMLAF.Check DNOPY's competition here
EMLAF vs AXFOF Comparison May 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 7.7B. In comparison, AXFOF has a market cap of 7.2B. Regarding current trading prices, EMLAF is priced at $33.66, while AXFOF trades at $33.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 68.69, whereas AXFOF's P/E ratio is 32.14. In terms of profitability, EMLAF's ROE is +0.02%, compared to AXFOF's ROE of +0.36%. Regarding short-term risk, EMLAF is more volatile compared to AXFOF. This indicates potentially higher risk in terms of short-term price fluctuations for EMLAF.Check AXFOF's competition here
EMLAF vs AXFOY Comparison May 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 7.7B. In comparison, AXFOY has a market cap of 5.9B. Regarding current trading prices, EMLAF is priced at $33.66, while AXFOY trades at $27.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 68.69, whereas AXFOY's P/E ratio is 26.71. In terms of profitability, EMLAF's ROE is +0.02%, compared to AXFOY's ROE of +0.36%. Regarding short-term risk, EMLAF is more volatile compared to AXFOY. This indicates potentially higher risk in terms of short-term price fluctuations for EMLAF.Check AXFOY's competition here
EMLAF vs DFIHY Comparison May 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 7.7B. In comparison, DFIHY has a market cap of 5.5B. Regarding current trading prices, EMLAF is priced at $33.66, while DFIHY trades at $20.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 68.69, whereas DFIHY's P/E ratio is -14.64. In terms of profitability, EMLAF's ROE is +0.02%, compared to DFIHY's ROE of +0.52%. Regarding short-term risk, EMLAF is more volatile compared to DFIHY. This indicates potentially higher risk in terms of short-term price fluctuations for EMLAF.Check DFIHY's competition here
EMLAF vs GCHEF Comparison May 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 7.7B. In comparison, GCHEF has a market cap of 5.4B. Regarding current trading prices, EMLAF is priced at $33.66, while GCHEF trades at $5.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 68.69, whereas GCHEF's P/E ratio is 14.13. In terms of profitability, EMLAF's ROE is +0.02%, compared to GCHEF's ROE of +0.13%. Regarding short-term risk, EMLAF is more volatile compared to GCHEF. This indicates potentially higher risk in terms of short-term price fluctuations for EMLAF.Check GCHEF's competition here
EMLAF vs KOBNF Comparison May 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 7.7B. In comparison, KOBNF has a market cap of 5.3B. Regarding current trading prices, EMLAF is priced at $33.66, while KOBNF trades at $24.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 68.69, whereas KOBNF's P/E ratio is 26.48. In terms of profitability, EMLAF's ROE is +0.02%, compared to KOBNF's ROE of +0.18%. Regarding short-term risk, EMLAF is more volatile compared to KOBNF. This indicates potentially higher risk in terms of short-term price fluctuations for EMLAF.Check KOBNF's competition here
EMLAF vs DFILF Comparison May 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 7.7B. In comparison, DFILF has a market cap of 5.2B. Regarding current trading prices, EMLAF is priced at $33.66, while DFILF trades at $3.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 68.69, whereas DFILF's P/E ratio is 22.65. In terms of profitability, EMLAF's ROE is +0.02%, compared to DFILF's ROE of +0.52%. Regarding short-term risk, EMLAF is less volatile compared to DFILF. This indicates potentially lower risk in terms of short-term price fluctuations for EMLAF.Check DFILF's competition here
EMLAF vs CUYTF Comparison May 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 7.7B. In comparison, CUYTF has a market cap of 4.5B. Regarding current trading prices, EMLAF is priced at $33.66, while CUYTF trades at $37.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 68.69, whereas CUYTF's P/E ratio is 12.52. In terms of profitability, EMLAF's ROE is +0.02%, compared to CUYTF's ROE of +0.09%. Regarding short-term risk, EMLAF is more volatile compared to CUYTF. This indicates potentially higher risk in terms of short-term price fluctuations for EMLAF.Check CUYTF's competition here
EMLAF vs CUYTY Comparison May 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 7.7B. In comparison, CUYTY has a market cap of 4.3B. Regarding current trading prices, EMLAF is priced at $33.66, while CUYTY trades at $9.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 68.69, whereas CUYTY's P/E ratio is 12.97. In terms of profitability, EMLAF's ROE is +0.02%, compared to CUYTY's ROE of +0.09%. Regarding short-term risk, EMLAF is less volatile compared to CUYTY. This indicates potentially lower risk in terms of short-term price fluctuations for EMLAF.Check CUYTY's competition here
EMLAF vs SHUFF Comparison May 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 7.7B. In comparison, SHUFF has a market cap of 3.4B. Regarding current trading prices, EMLAF is priced at $33.66, while SHUFF trades at $12.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 68.69, whereas SHUFF's P/E ratio is 16.04. In terms of profitability, EMLAF's ROE is +0.02%, compared to SHUFF's ROE of +0.18%. Regarding short-term risk, EMLAF is less volatile compared to SHUFF. This indicates potentially lower risk in terms of short-term price fluctuations for EMLAF.Check SHUFF's competition here
EMLAF vs BMBRF Comparison May 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 7.7B. In comparison, BMBRF has a market cap of 3.4B. Regarding current trading prices, EMLAF is priced at $33.66, while BMBRF trades at $5.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 68.69, whereas BMBRF's P/E ratio is 16.91. In terms of profitability, EMLAF's ROE is +0.02%, compared to BMBRF's ROE of +0.13%. Regarding short-term risk, EMLAF is less volatile compared to BMBRF. This indicates potentially lower risk in terms of short-term price fluctuations for EMLAF.Check BMBRF's competition here
EMLAF vs GGGSF Comparison May 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 7.7B. In comparison, GGGSF has a market cap of 2.3B. Regarding current trading prices, EMLAF is priced at $33.66, while GGGSF trades at $22.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 68.69, whereas GGGSF's P/E ratio is 13.76. In terms of profitability, EMLAF's ROE is +0.02%, compared to GGGSF's ROE of +0.20%. Regarding short-term risk, EMLAF is less volatile compared to GGGSF. This indicates potentially lower risk in terms of short-term price fluctuations for EMLAF.Check GGGSF's competition here
EMLAF vs GGGSY Comparison May 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 7.7B. In comparison, GGGSY has a market cap of 2.3B. Regarding current trading prices, EMLAF is priced at $33.66, while GGGSY trades at $7.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 68.69, whereas GGGSY's P/E ratio is 13.74. In terms of profitability, EMLAF's ROE is +0.02%, compared to GGGSY's ROE of +0.20%. Regarding short-term risk, EMLAF is more volatile compared to GGGSY. This indicates potentially higher risk in terms of short-term price fluctuations for EMLAF.Check GGGSY's competition here
EMLAF vs OCDGF Comparison May 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 7.7B. In comparison, OCDGF has a market cap of 2.2B. Regarding current trading prices, EMLAF is priced at $33.66, while OCDGF trades at $2.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 68.69, whereas OCDGF's P/E ratio is -4.05. In terms of profitability, EMLAF's ROE is +0.02%, compared to OCDGF's ROE of +0.24%. Regarding short-term risk, EMLAF is less volatile compared to OCDGF. This indicates potentially lower risk in terms of short-term price fluctuations for EMLAF.Check OCDGF's competition here
EMLAF vs OCDDY Comparison May 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 7.7B. In comparison, OCDDY has a market cap of 2.1B. Regarding current trading prices, EMLAF is priced at $33.66, while OCDDY trades at $4.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 68.69, whereas OCDDY's P/E ratio is -3.92. In terms of profitability, EMLAF's ROE is +0.02%, compared to OCDDY's ROE of +0.06%. Regarding short-term risk, EMLAF is less volatile compared to OCDDY. This indicates potentially lower risk in terms of short-term price fluctuations for EMLAF.Check OCDDY's competition here
EMLAF vs NNWWF Comparison May 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 7.7B. In comparison, NNWWF has a market cap of 1.7B. Regarding current trading prices, EMLAF is priced at $33.66, while NNWWF trades at $37.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 68.69, whereas NNWWF's P/E ratio is 17.37. In terms of profitability, EMLAF's ROE is +0.02%, compared to NNWWF's ROE of +0.18%. Regarding short-term risk, EMLAF is more volatile compared to NNWWF. This indicates potentially higher risk in terms of short-term price fluctuations for EMLAF.Check NNWWF's competition here
EMLAF vs CGUSY Comparison May 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 7.7B. In comparison, CGUSY has a market cap of 1.7B. Regarding current trading prices, EMLAF is priced at $33.66, while CGUSY trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 68.69, whereas CGUSY's P/E ratio is -0.00. In terms of profitability, EMLAF's ROE is +0.02%, compared to CGUSY's ROE of -33.50%. Regarding short-term risk, EMLAF is more volatile compared to CGUSY. This indicates potentially higher risk in terms of short-term price fluctuations for EMLAF.Check CGUSY's competition here
EMLAF vs RLEVF Comparison May 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 7.7B. In comparison, RLEVF has a market cap of 1B. Regarding current trading prices, EMLAF is priced at $33.66, while RLEVF trades at $74.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 68.69, whereas RLEVF's P/E ratio is 15.38. In terms of profitability, EMLAF's ROE is +0.02%, compared to RLEVF's ROE of +0.39%. Regarding short-term risk, EMLAF is less volatile compared to RLEVF. This indicates potentially lower risk in terms of short-term price fluctuations for EMLAF.Check RLEVF's competition here
EMLAF vs EUSHY Comparison May 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 7.7B. In comparison, EUSHY has a market cap of 267.9M. Regarding current trading prices, EMLAF is priced at $33.66, while EUSHY trades at $1.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 68.69, whereas EUSHY's P/E ratio is -38.50. In terms of profitability, EMLAF's ROE is +0.02%, compared to EUSHY's ROE of -0.72%. Regarding short-term risk, EMLAF is less volatile compared to EUSHY. This indicates potentially lower risk in terms of short-term price fluctuations for EMLAF.Check EUSHY's competition here
EMLAF vs EUSHF Comparison May 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 7.7B. In comparison, EUSHF has a market cap of 238M. Regarding current trading prices, EMLAF is priced at $33.66, while EUSHF trades at $1.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 68.69, whereas EUSHF's P/E ratio is -10.69. In terms of profitability, EMLAF's ROE is +0.02%, compared to EUSHF's ROE of -0.71%. Regarding short-term risk, EMLAF is more volatile compared to EUSHF. This indicates potentially higher risk in terms of short-term price fluctuations for EMLAF.Check EUSHF's competition here
EMLAF vs CGUIF Comparison May 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 7.7B. In comparison, CGUIF has a market cap of 91M. Regarding current trading prices, EMLAF is priced at $33.66, while CGUIF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 68.69, whereas CGUIF's P/E ratio is -0.03. In terms of profitability, EMLAF's ROE is +0.02%, compared to CGUIF's ROE of -0.50%. Regarding short-term risk, EMLAF is more volatile compared to CGUIF. This indicates potentially higher risk in terms of short-term price fluctuations for EMLAF.Check CGUIF's competition here
EMLAF vs HCMC Comparison May 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 7.7B. In comparison, HCMC has a market cap of 26.4M. Regarding current trading prices, EMLAF is priced at $33.66, while HCMC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 68.69, whereas HCMC's P/E ratio is N/A. In terms of profitability, EMLAF's ROE is +0.02%, compared to HCMC's ROE of +2.94%. Regarding short-term risk, EMLAF is less volatile compared to HCMC. This indicates potentially lower risk in terms of short-term price fluctuations for EMLAF.Check HCMC's competition here
EMLAF vs FLOCF Comparison May 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 7.7B. In comparison, FLOCF has a market cap of 6.2M. Regarding current trading prices, EMLAF is priced at $33.66, while FLOCF trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 68.69, whereas FLOCF's P/E ratio is -0.25. In terms of profitability, EMLAF's ROE is +0.02%, compared to FLOCF's ROE of +2.82%. Regarding short-term risk, EMLAF is more volatile compared to FLOCF. This indicates potentially higher risk in terms of short-term price fluctuations for EMLAF.Check FLOCF's competition here
EMLAF vs MTVX Comparison May 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 7.7B. In comparison, MTVX has a market cap of 822.8K. Regarding current trading prices, EMLAF is priced at $33.66, while MTVX trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 68.69, whereas MTVX's P/E ratio is N/A. In terms of profitability, EMLAF's ROE is +0.02%, compared to MTVX's ROE of +0.39%. Regarding short-term risk, EMLAF is more volatile compared to MTVX. This indicates potentially higher risk in terms of short-term price fluctuations for EMLAF.Check MTVX's competition here
EMLAF vs OMHI Comparison May 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 7.7B. In comparison, OMHI has a market cap of 20.9K. Regarding current trading prices, EMLAF is priced at $33.66, while OMHI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 68.69, whereas OMHI's P/E ratio is N/A. In terms of profitability, EMLAF's ROE is +0.02%, compared to OMHI's ROE of +0.15%. Regarding short-term risk, EMLAF is less volatile compared to OMHI. This indicates potentially lower risk in terms of short-term price fluctuations for EMLAF.Check OMHI's competition here
EMLAF vs IFMK Comparison May 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 7.7B. In comparison, IFMK has a market cap of 9.6K. Regarding current trading prices, EMLAF is priced at $33.66, while IFMK trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 68.69, whereas IFMK's P/E ratio is N/A. In terms of profitability, EMLAF's ROE is +0.02%, compared to IFMK's ROE of +4.63%. Regarding short-term risk, EMLAF is more volatile compared to IFMK. This indicates potentially higher risk in terms of short-term price fluctuations for EMLAF.Check IFMK's competition here
EMLAF vs HWIN Comparison May 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 7.7B. In comparison, HWIN has a market cap of 3.6K. Regarding current trading prices, EMLAF is priced at $33.66, while HWIN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 68.69, whereas HWIN's P/E ratio is N/A. In terms of profitability, EMLAF's ROE is +0.02%, compared to HWIN's ROE of -0.37%. Regarding short-term risk, EMLAF is less volatile compared to HWIN. This indicates potentially lower risk in terms of short-term price fluctuations for EMLAF.Check HWIN's competition here
EMLAF vs MFLTY Comparison May 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 7.7B. In comparison, MFLTY has a market cap of 1.6K. Regarding current trading prices, EMLAF is priced at $33.66, while MFLTY trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 68.69, whereas MFLTY's P/E ratio is N/A. In terms of profitability, EMLAF's ROE is +0.02%, compared to MFLTY's ROE of +1.75%. Regarding short-term risk, EMLAF is less volatile compared to MFLTY. This indicates potentially lower risk in terms of short-term price fluctuations for EMLAF.Check MFLTY's competition here
EMLAF vs QKLS Comparison May 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 7.7B. In comparison, QKLS has a market cap of 152. Regarding current trading prices, EMLAF is priced at $33.66, while QKLS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 68.69, whereas QKLS's P/E ratio is N/A. In terms of profitability, EMLAF's ROE is +0.02%, compared to QKLS's ROE of -2.85%. Regarding short-term risk, EMLAF is more volatile compared to QKLS. This indicates potentially higher risk in terms of short-term price fluctuations for EMLAF.Check QKLS's competition here